{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:20:35Z","timestamp":1791584435460,"version":"4.3.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"crossref","award":["C052302"],"award-info":[{"award-number":["C052302"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07355-9","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:03:31Z","timestamp":1764072211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrative pan-cancer analysis of intratumoral microbial communities for biomarker discovery and diagnostic modeling"],"prefix":"10.1186","volume":"23","author":[{"given":"Liuliu","family":"Quan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiteng","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-0368","authenticated-orcid":false,"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"8","key":"7355_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"Tumor-resident intracellular","year":"2022","unstructured":"Tumor-resident intracellular. Microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356\u2013e7226.","journal-title":"Cell"},{"key":"7355_CR2","doi-asserted-by":"publisher","unstructured":"Chang CM, Pekkle Lam HY. Intratumoral microbiota: unraveling their oncogenic impact on cancer progression with focus on breast cancer therapeutic outcomes. Anticancer Res. 2024;44(6):2271\u201385. https:\/\/doi.org\/10.21873\/anticanres.17035.","DOI":"10.21873\/anticanres.17035"},{"key":"7355_CR3","doi-asserted-by":"crossref","unstructured":"Li T, Coker OO, Sun Y, et al. Multi-cohort analysis reveals altered archaea in colorectal cancer fecal samples across populations. Gastroenterology. 2025.","DOI":"10.1053\/j.gastro.2024.10.023"},{"key":"7355_CR4","doi-asserted-by":"crossref","unstructured":"Parida S, Siddharth S, Xia Y, Sharma D. Concomitant analyses of intratumoral microbiota and genomic features reveal distinct Racial differences in breast cancer. npj Breast Cancer. 2023.","DOI":"10.1038\/s41523-023-00505-6"},{"key":"7355_CR5","doi-asserted-by":"crossref","unstructured":"Qin W, Li J, Gao N, et al. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer. Mol Cancer. 2024;23(1).","DOI":"10.1186\/s12943-024-02017-8"},{"key":"7355_CR6","doi-asserted-by":"publisher","unstructured":"Xie Y, Xie F, Zhou X, et al. Microbiota in tumors: from understanding to application. Adv Sci (Weinh). 2022;9(21):e2200470. https:\/\/doi.org\/10.1002\/advs.202200470","DOI":"10.1002\/advs.202200470"},{"issue":"6494","key":"7355_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, et al. The human tumor Microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973\u201380. https:\/\/doi.org\/10.1126\/science.aay9189.","journal-title":"Science"},{"issue":"1","key":"7355_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4103\/sajc.sajc_82_17","volume":"7","author":"S Abd-Elsalam","year":"2018","unstructured":"Abd-Elsalam S, Elwan N, Soliman H, et al. Epidemiology of liver cancer in nile delta over a decade: A single-center study. South Asian J Cancer. 2018;7(1):24\u20136. https:\/\/doi.org\/10.4103\/sajc.sajc_82_17.","journal-title":"South Asian J Cancer"},{"issue":"2","key":"7355_CR9","doi-asserted-by":"publisher","first-page":"Oc32","DOI":"10.7860\/jcdr\/2017\/23095.9450","volume":"11","author":"M Watany","year":"2017","unstructured":"Watany M, Badawi R, Elkhalawany W, Abd-Elsalam S. Study of Dickkopf-1 (DKK-1) gene expression in hepatocellular carcinoma patients. J Clin Diagn Res. 2017;11(2):Oc32. https:\/\/doi.org\/10.7860\/jcdr\/2017\/23095.9450.","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"7355_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, et al. Cancer Incidence, Mortality, years of life Lost, years lived with Disability, and Disability-Adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987.","journal-title":"JAMA Oncol"},{"key":"7355_CR11","doi-asserted-by":"publisher","unstructured":"Elhendawy M, Abdul-Baki EA, Abd-Elsalam S, et al. MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers. Mol Biol Rep. 2020;47(7):4945\u201353. https:\/\/doi.org\/10.1007\/s11033-020-05521-4.","DOI":"10.1007\/s11033-020-05521-4"},{"issue":"10352","key":"7355_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/s0140-6736(22)01438-6","volume":"400","author":"The global burden of cancer attributable to risk factors","year":"2022","unstructured":"The global burden of cancer attributable to risk factors. 2010-19: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563\u201391. https:\/\/doi.org\/10.1016\/s0140-6736(22)01438-6.","journal-title":"Lancet"},{"key":"7355_CR13","doi-asserted-by":"publisher","first-page":"217077","DOI":"10.1016\/j.canlet.2024.217077","volume":"598","author":"D Sheng","year":"2024","unstructured":"Sheng D, Jin C, Yue K, et al. Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis. Cancer Lett. 2024;598:217077. https:\/\/doi.org\/10.1016\/j.canlet.2024.217077.","journal-title":"Cancer Lett"},{"issue":"2","key":"7355_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.chom.2020.12.001","volume":"29","author":"AB Dohlman","year":"2021","unstructured":"Dohlman AB, Arguijo Mendoza D, Ding S, et al. The cancer Microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 2021;29(2):281\u201398. https:\/\/doi.org\/10.1016\/j.chom.2020.12.001.","journal-title":"Cell Host Microbe"},{"issue":"9","key":"7355_CR15","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, et al. A pan-cancer analysis of the Microbiome in metastatic cancer. Cell. 2024;187(9):2324\u201335. https:\/\/doi.org\/10.1016\/j.cell.2024.03.021.","journal-title":"Cell"},{"key":"7355_CR16","doi-asserted-by":"publisher","unstructured":"Zhao L, Cho WCS, Luo JL. Exploring the patient-microbiome interaction patterns for pan-cancer. Comput Struct Biotechnol J. 2022;20:3068\u201379. https:\/\/doi.org\/10.1016\/j.csbj.2022.06.012.","DOI":"10.1016\/j.csbj.2022.06.012"},{"issue":"1","key":"7355_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-023-04411-0","volume":"21","author":"SW Guan","year":"2023","unstructured":"Guan SW, Lin Q, Wu XD, Yu HB. Weighted gene coexpression network analysis and machine learning reveal oncogenome associated Microbiome plays an important role in tumor immunity and prognosis in pan-cancer. J Transl Med. 2023;21(1):537. https:\/\/doi.org\/10.1186\/s12967-023-04411-0.","journal-title":"J Transl Med"},{"key":"7355_CR18","doi-asserted-by":"publisher","unstructured":"Chen C, Cai Y, Liu Y, et al. Pan-Cancer analysis of Microbiome quantitative trait loci. Cancer Res. 2022;82(19):3449\u201356. https:\/\/doi.org\/10.1158\/0008-5472.can-22-1854.","DOI":"10.1158\/0008-5472.can-22-1854"},{"issue":"7964","key":"7355_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","volume":"618","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2023","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Movasati A, Brunner SR, et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature. 2023;618(7964):333\u201341. https:\/\/doi.org\/10.1038\/s41586-023-06054-z.","journal-title":"Nature"},{"issue":"18","key":"7355_CR20","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","volume":"186","author":"Y Geffen","year":"2023","unstructured":"Geffen Y, Anand S, Akiyama Y, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023;186(18):3945\u201367. https:\/\/doi.org\/10.1016\/j.cell.2023.07.013.","journal-title":"Cell"},{"issue":"3","key":"7355_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.path.2021.05.012","volume":"14","author":"F Dong","year":"2021","unstructured":"Dong F. Pan-Cancer molecular biomarkers: A paradigm shift in diagnostic pathology. Surg Pathol Clin. 2021;14(3):507\u2013. https:\/\/doi.org\/10.1016\/j.path.2021.05.012.","journal-title":"Surg Pathol Clin"},{"key":"7355_CR22","doi-asserted-by":"publisher","first-page":"916594","DOI":"10.3389\/fimmu.2022.916594","volume":"13","author":"Z Feng","year":"2022","unstructured":"Feng Z, Chen Y, Cai C, et al. Pan-Cancer and Single-Cell analysis reveals CENPL as a cancer prognosis and immune Infiltration-Related biomarker. Front Immunol. 2022;13:916594. https:\/\/doi.org\/10.3389\/fimmu.2022.916594.","journal-title":"Front Immunol"},{"key":"7355_CR23","doi-asserted-by":"publisher","first-page":"111107","DOI":"10.1016\/j.cellsig.2024.111107","volume":"117","author":"W Yang","year":"2024","unstructured":"Yang W, Liu Z, Liu T. Pan-cancer analysis predicts CANT1 as a potential prognostic, Immunologic biomarker. Cell Signal. 2024;117:111107. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111107.","journal-title":"Cell Signal"},{"key":"7355_CR24","doi-asserted-by":"publisher","first-page":"104207","DOI":"10.1016\/j.ebiom.2022.104207","volume":"83","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Chen L, Chen H, et al. Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy. EBioMedicine. 2022;83:104207. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104207.","journal-title":"EBioMedicine"},{"issue":"7800","key":"7355_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore GD, Kopylova E, Zhu Q, Carpenter C, Knight R. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579(7800):1\u20138.","journal-title":"Nature"},{"issue":"7480","key":"7355_CR26","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446\u201350. https:\/\/doi.org\/10.1038\/nature12721.","journal-title":"Nature"},{"key":"7355_CR27","doi-asserted-by":"publisher","unstructured":"Routy B, Lenehan JG, Miller WH Jr., et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat Med. 2023;29(8):2121\u201332. https:\/\/doi.org\/10.1038\/s41591-023-02453-x.","DOI":"10.1038\/s41591-023-02453-x"},{"key":"7355_CR28","doi-asserted-by":"publisher","unstructured":"Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371(6529):602\u20139. https:\/\/doi.org\/10.1126\/science.abb5920.","DOI":"10.1126\/science.abb5920"},{"issue":"12","key":"7355_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","volume":"20","author":"A M\u00f6ller","year":"2020","unstructured":"M\u00f6ller A, Lobb RJ. The evolving translational potential of small extracellular vesicles in cancer. Nat Rev Cancer. 2020;20(12):697\u2013709. https:\/\/doi.org\/10.1038\/s41568-020-00299-w.","journal-title":"Nat Rev Cancer"},{"key":"7355_CR30","doi-asserted-by":"publisher","first-page":"1310054","DOI":"10.3389\/fonc.2023.1310054","volume":"13","author":"HJ An","year":"2023","unstructured":"An HJ, Partha MA, Lee H, et al. Tumor-associated Microbiome features of metastatic colorectal cancer and clinical implications. Front Oncol. 2023;13:1310054. https:\/\/doi.org\/10.3389\/fonc.2023.1310054.","journal-title":"Front Oncol"},{"key":"7355_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215421","volume":"13","author":"A Borgognone","year":"2021","unstructured":"Borgognone A, Serna G, Noguera-Julian M, et al. Performance of 16S metagenomic profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen colorectal cancer tissues. Cancers (Basel). 2021;13:21. https:\/\/doi.org\/10.3390\/cancers13215421.","journal-title":"Cancers (Basel)"},{"key":"7355_CR32","doi-asserted-by":"publisher","unstructured":"Burns MB, Lynch J, Starr TK, Knights D, Blekhman R. Virulence genes are a signature of the Microbiome in the colorectal tumor microenvironment. Genome Med. 2015;7(1):55. https:\/\/doi.org\/10.1186\/s13073-015-0177-8.","DOI":"10.1186\/s13073-015-0177-8"},{"issue":"1","key":"7355_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13099-024-00631-x","volume":"16","author":"N Dovrolis","year":"2024","unstructured":"Dovrolis N, Gazouli M, Rigal F, et al. Power-law scaling in intratumoral microbiota of colorectal cancer. Gut Pathog. 2024;16(1):34. https:\/\/doi.org\/10.1186\/s13099-024-00631-x.","journal-title":"Gut Pathog"},{"key":"7355_CR34","doi-asserted-by":"publisher","unstructured":"Galeano Ni\u00f1o JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on Spatial and cellular heterogeneity in cancer. Nature. 2022;611(7937):810\u20137. https:\/\/doi.org\/10.1038\/s41586-022-05435-0.","DOI":"10.1038\/s41586-022-05435-0"},{"issue":"1","key":"7355_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1757-4749-5-2","volume":"5","author":"J Geng","year":"2013","unstructured":"Geng J, Fan H, Tang X, Zhai H, Zhang Z. Diversified pattern of the human colorectal cancer Microbiome. Gut Pathog. 2013;5(1):2. https:\/\/doi.org\/10.1186\/1757-4749-5-2.","journal-title":"Gut Pathog"},{"key":"7355_CR36","doi-asserted-by":"publisher","first-page":"217149","DOI":"10.1016\/j.canlet.2024.217149","volume":"601","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang R, Fu C, et al. Intratumoral Microbiome promotes liver metastasis and dampens adjuvant Imatinib treatment in Gastrointestinal stromal tumor. Cancer Lett. 2024;601:217149. https:\/\/doi.org\/10.1016\/j.canlet.2024.217149.","journal-title":"Cancer Lett"},{"key":"7355_CR37","doi-asserted-by":"publisher","unstructured":"Mansour B, Mony\u00f3k \u00c1, Gajd\u00e1cs M, et al. Bladder tissue Microbiome composition in patients of bladder cancer or benign prostatic hyperplasia and related human beta defensin levels. Biomedicines. 2022;10(7). https:\/\/doi.org\/10.3390\/biomedicines10071758.","DOI":"10.3390\/biomedicines10071758"},{"key":"7355_CR38","doi-asserted-by":"publisher","unstructured":"Noguti J, Chan AA, Bandera B, et al. Both the intratumoral immune and microbial microenvironment are linked to recurrence in human colon cancer: results from a prospective, multicenter nodal ultrastaging trial. Oncotarget. 2018;9(34):23564\u201376. https:\/\/doi.org\/10.18632\/oncotarget.25276.","DOI":"10.18632\/oncotarget.25276"},{"key":"7355_CR39","doi-asserted-by":"publisher","unstructured":"Pratap Singh R, Kumari N, Gupta S, et al. Intratumoral microbiota changes with tumor stage and influences the immune signature of oral squamous cell carcinoma. Microbiol Spectr. 2023;11(4):e0459622. https:\/\/doi.org\/10.1128\/spectrum.04596-22.","DOI":"10.1128\/spectrum.04596-22"},{"key":"7355_CR40","unstructured":"Thank you for your message. Reference 40 is a duplicate of Reference and should be deleted. There is no additional reference to replace it. Please remove Reference 40 and renumber the subsequent references accordingly. I apologize for the inconvenience caused, and thank you for your understanding and assistance."},{"issue":"37","key":"7355_CR41","doi-asserted-by":"publisher","first-page":"e30483","DOI":"10.1097\/md.0000000000030483","volume":"101","author":"B Zhang","year":"2022","unstructured":"Zhang B, Xiao Q, Chen H, Zhou T, Yin Y. Comparison of tumor-associated and nontumor-associated esophageal mucosa microbiota in patients with esophageal squamous cell carcinoma. Med (Baltim). 2022;101(37):e30483. https:\/\/doi.org\/10.1097\/md.0000000000030483.","journal-title":"Med (Baltim)"},{"issue":"Database issue","key":"7355_CR42","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136. https:\/\/doi.org\/10.1093\/nar\/gks1219.","journal-title":"Nucleic Acids Res"},{"key":"7355_CR43","doi-asserted-by":"publisher","first-page":"796025","DOI":"10.3389\/fmicb.2021.796025","volume":"12","author":"JG Kers","year":"2021","unstructured":"Kers JG, Saccenti E. The power of Microbiome studies: some considerations on which alpha and beta metrics to use and how to report results. Front Microbiol. 2021;12:796025. https:\/\/doi.org\/10.3389\/fmicb.2021.796025.","journal-title":"Front Microbiol"},{"key":"7355_CR44","doi-asserted-by":"publisher","unstructured":"Bhanu P, Buchke S, Hemandhar-Kumar N, et al. Comparative metagenomic analysis of the oral Microbiome in COVID-19 patients and healthy individuals. Sci Rep. 2025;15(1):10303. https:\/\/doi.org\/10.1038\/s41598-024-81864-3.","DOI":"10.1038\/s41598-024-81864-3"},{"issue":"1","key":"7355_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40168-020-00857-2","volume":"8","author":"B Ma","year":"2020","unstructured":"Ma B, Wang Y, Ye S, et al. Earth microbial co-occurrence network reveals interconnection pattern across microbiomes. Microbiome. 2020;8(1):82. https:\/\/doi.org\/10.1186\/s40168-020-00857-2.","journal-title":"Microbiome"},{"key":"7355_CR46","doi-asserted-by":"publisher","unstructured":"Wen T, Liu YX, Liu L, et al. GgClusterNet 2: an R package for microbial co-occurrence networks and associated indicator correlation patterns. Imeta. 2025;4(3):e70041. https:\/\/doi.org\/10.1002\/imt2.70041.","DOI":"10.1002\/imt2.70041"},{"key":"7355_CR47","doi-asserted-by":"publisher","first-page":"125478","DOI":"10.1016\/j.jenvman.2025.125478","volume":"383","author":"J Han","year":"2025","unstructured":"Han J, Guzman JA, Chu ML. Prediction of gully erosion susceptibility through the lens of the SHapley additive explanations (SHAP) method using a stacking ensemble model. J Environ Manage. 2025;383:125478. https:\/\/doi.org\/10.1016\/j.jenvman.2025.125478.","journal-title":"J Environ Manage"},{"key":"7355_CR48","doi-asserted-by":"publisher","first-page":"1348974","DOI":"10.3389\/fmicb.2024.1348974","volume":"15","author":"P Novielli","year":"2024","unstructured":"Novielli P, Romano D, Magarelli M, et al. Explainable artificial intelligence for Microbiome data analysis in colorectal cancer biomarker identification. Front Microbiol. 2024;15:1348974. https:\/\/doi.org\/10.3389\/fmicb.2024.1348974.","journal-title":"Front Microbiol"},{"key":"7355_CR49","doi-asserted-by":"publisher","first-page":"942328","DOI":"10.3389\/fcimb.2022.942328","volume":"12","author":"B Zeng","year":"2022","unstructured":"Zeng B, Tan J, Guo G, et al. The oral cancer Microbiome contains tumor space-specific and clinicopathology-specific bacteria. Front Cell Infect Microbiol. 2022;12:942328. https:\/\/doi.org\/10.3389\/fcimb.2022.942328.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"7355_CR50","doi-asserted-by":"publisher","first-page":"8766","DOI":"10.1038\/s41598-022-12658-8","volume":"12","author":"S Okuda","year":"2022","unstructured":"Okuda S, Hirose Y, Takihara H, et al. Unveiling Microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer. Sci Rep. 2022;12(1):8766. https:\/\/doi.org\/10.1038\/s41598-022-12658-8.","journal-title":"Sci Rep"},{"issue":"4","key":"7355_CR51","doi-asserted-by":"publisher","first-page":"e0249832","DOI":"10.1371\/journal.pone.0249832","volume":"16","author":"N Dumont-Leblond","year":"2021","unstructured":"Dumont-Leblond N, Veillette M, Racine C, Joubert P, Duchaine C. Non-small cell lung cancer microbiota characterization: prevalence of enteric and potentially pathogenic bacteria in cancer tissues. PLoS ONE. 2021;16(4):e0249832. https:\/\/doi.org\/10.1371\/journal.pone.0249832.","journal-title":"PLoS ONE"},{"issue":"1","key":"7355_CR52","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12885-024-12202-z","volume":"24","author":"F Zhao","year":"2024","unstructured":"Zhao F, Chen A, Wu X, Deng X, Yang J, Xue J. Heterogeneous changes in gut and tumor microbiota in patients with pancreatic cancer: insights from clinical evidence. BMC Cancer. 2024;24(1):478. https:\/\/doi.org\/10.1186\/s12885-024-12202-z.","journal-title":"BMC Cancer"},{"key":"7355_CR53","doi-asserted-by":"publisher","unstructured":"Gao Y, Zhang H, Chu D, Ning K. Intra-tumor microbiome-based tumor survival indices predict immune interaction and drug sensitivity on pan-cancer scale. mSystems. 2025;e0031225. https:\/\/doi.org\/10.1128\/msystems.00312-25.","DOI":"10.1128\/msystems.00312-25"},{"key":"7355_CR54","doi-asserted-by":"publisher","unstructured":"Zhang H, Xiong X, Cheng M, Ji L, Ning K. Deep learning enabled integration of tumor microenvironment microbial profiles and host gene expressions for interpretable survival subtyping in diverse types of cancers. mSystems. 2024;9(12):e0139524. https:\/\/doi.org\/10.1128\/msystems.01395-24.","DOI":"10.1128\/msystems.01395-24"},{"key":"7355_CR55","doi-asserted-by":"publisher","first-page":"1244752","DOI":"10.3389\/fphar.2023.1244752","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, Liu J, Li H, et al. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients. Front Pharmacol. 2023;14:1244752. https:\/\/doi.org\/10.3389\/fphar.2023.1244752.","journal-title":"Front Pharmacol"},{"key":"7355_CR56","doi-asserted-by":"publisher","unstructured":"Yerukala Sathipati S, Tsai MJ, Shukla SK, Ho SY. Artificial intelligence-driven pan-cancer analysis reveals MiRNA signatures for cancer stage prediction. HGG Adv. 2023;4(3):100190. https:\/\/doi.org\/10.1016\/j.xhgg.2023.100190.","DOI":"10.1016\/j.xhgg.2023.100190"},{"issue":"1","key":"7355_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12859-024-05870-y","volume":"25","author":"X Zhao","year":"2024","unstructured":"Zhao X, Chen Z, Wang H, Sun H. Occlusion enhanced pan-cancer classification via deep learning. BMC Bioinformatics. 2024;25(1):260. https:\/\/doi.org\/10.1186\/s12859-024-05870-y.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"7355_CR58","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8(1):80\u201393. https:\/\/doi.org\/10.1038\/mi.2014.44.","journal-title":"Mucosal Immunol"},{"key":"7355_CR59","doi-asserted-by":"publisher","first-page":"677605","DOI":"10.3389\/fonc.2021.677605","volume":"11","author":"W Ma","year":"2021","unstructured":"Ma W, Zhang W, Shen L, et al. Can smoking cause differences in urine Microbiome in male patients with bladder cancer? A retrospective study. Front Oncol. 2021;11:677605. https:\/\/doi.org\/10.3389\/fonc.2021.677605.","journal-title":"Front Oncol"},{"issue":"1","key":"7355_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-024-05173-0","volume":"42","author":"PV Stamatakos","year":"2024","unstructured":"Stamatakos PV, Fragkoulis C, Zoidakis I, et al. A review of urinary bladder Microbiome in patients with bladder cancer and its implications in bladder pathogenesis. World J Urol. 2024;42(1):457. https:\/\/doi.org\/10.1007\/s00345-024-05173-0.","journal-title":"World J Urol"},{"issue":"19","key":"7355_CR61","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.21037\/atm-20-2976","volume":"8","author":"M Nicolaro","year":"2020","unstructured":"Nicolaro M, Portal DE, Shinder B, Patel HV, Singer EA. The human Microbiome and genitourinary malignancies. Ann Transl Med. 2020;8(19):1245. https:\/\/doi.org\/10.21037\/atm-20-2976.","journal-title":"Ann Transl Med"},{"issue":"2","key":"7355_CR62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/nau.23900","volume":"38","author":"JJJ Wyndaele","year":"2019","unstructured":"Wyndaele JJJ, Riedl C, Taneja R, Lov\u00e1sz S, Ueda T, Cervigni M. GAG replenishment therapy for bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2019;38(2):535\u201344. https:\/\/doi.org\/10.1002\/nau.23900.","journal-title":"Neurourol Urodyn"},{"key":"7355_CR63","doi-asserted-by":"publisher","unstructured":"Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852\u20137. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","DOI":"10.1038\/s41587-019-0209-9"},{"key":"7355_CR64","doi-asserted-by":"publisher","unstructured":"Wang Q, Hu T, Zhang Q, et al. Fusobacterium nucleatum promotes colorectal cancer through neogenesis of tumor stem cells. J Clin Invest. 2025;135(3). https:\/\/doi.org\/10.1172\/jci181595.","DOI":"10.1172\/jci181595"},{"key":"7355_CR65","doi-asserted-by":"publisher","unstructured":"Borowsky J, Haruki K, Lau MC, et al. Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment. Clin Cancer Res. 2021;27(10):2816\u201326. https:\/\/doi.org\/10.1158\/1078-0432.ccr-20-4009.","DOI":"10.1158\/1078-0432.ccr-20-4009"},{"issue":"2","key":"7355_CR66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14(2):195\u2013206. https:\/\/doi.org\/10.1016\/j.chom.2013.07.012.","journal-title":"Cell Host Microbe"},{"key":"7355_CR67","first-page":"19","volume":"8","author":"Y Chen","year":"2017","unstructured":"Chen Y, Peng Y, Yu J, et al. Invasive Fusobacterium nucleatum activates beta-catenin signaling in colorectal cancer via a TLR4\/P-PAK1 cascade. Oncotarget. 2017;8:19.","journal-title":"Oncotarget"},{"key":"7355_CR68","doi-asserted-by":"publisher","unstructured":"Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443\u20138. https:\/\/doi.org\/10.1126\/science.aal5240.","DOI":"10.1126\/science.aal5240"},{"key":"7355_CR69","doi-asserted-by":"publisher","unstructured":"Huh J-W, Kim MJ, Kim J, et al. Enterotypical prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer. Microbiome. 2022;10(1):203. https:\/\/doi.org\/10.1186\/s40168-022-01388-8.","DOI":"10.1186\/s40168-022-01388-8"},{"issue":"1","key":"7355_CR70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z.","journal-title":"Br J Cancer"},{"key":"7355_CR71","doi-asserted-by":"publisher","unstructured":"Pallares-Mendez R, Brassetti A, Bove AM, Simone G. Insights into the interplay between the urinary Microbiome and bladder cancer: a comprehensive review. J Clin Med. 2024;13(16). https:\/\/doi.org\/10.3390\/jcm13164927","DOI":"10.3390\/jcm13164927"},{"key":"7355_CR72","doi-asserted-by":"publisher","first-page":"103065","DOI":"10.1016\/j.tice.2025.103065","volume":"97","author":"Y Yang","year":"2025","unstructured":"Yang Y, Chen Y, Liu Q, Guan L, Liang G. Fusobacterium nucleatum promotes bladder cancer progression and immune escape by activating the IL22\/STAT3\/PD-L1 signaling cascade. Tissue Cell. 2025;97:103065. https:\/\/doi.org\/10.1016\/j.tice.2025.103065.","journal-title":"Tissue Cell"},{"issue":"1","key":"7355_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13058-023-01677-6","volume":"25","author":"R German","year":"2023","unstructured":"German R, Marino N, Hemmerich C, et al. Exploring breast tissue microbial composition and the association with breast cancer risk factors. Breast Cancer Res. 2023;25(1):82. https:\/\/doi.org\/10.1186\/s13058-023-01677-6.","journal-title":"Breast Cancer Res"},{"key":"7355_CR74","doi-asserted-by":"publisher","first-page":"1163359","DOI":"10.3389\/fonc.2023.1163359","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Wu G, Yang J, et al. Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion. Front Oncol. 2023;13:1163359. https:\/\/doi.org\/10.3389\/fonc.2023.1163359.","journal-title":"Front Oncol"},{"key":"7355_CR75","doi-asserted-by":"publisher","first-page":"1029905","DOI":"10.3389\/fcimb.2022.1029905","volume":"12","author":"N Wang","year":"2022","unstructured":"Wang N, Yang J, Han W, et al. Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer. Front Cell Infect Microbiol. 2022;12:1029905. https:\/\/doi.org\/10.3389\/fcimb.2022.1029905.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"7355_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12866-021-02375-z","volume":"21","author":"S Najafi","year":"2021","unstructured":"Najafi S, Abedini F, Azimzadeh Jamalkandi S, Shariati P, Ahmadi A, Gholami Fesharaki M. The composition of lung Microbiome in lung cancer: a systematic review and meta-analysis. BMC Microbiol. 2021;21(1):315. https:\/\/doi.org\/10.1186\/s12866-021-02375-z.","journal-title":"BMC Microbiol"},{"key":"7355_CR77","doi-asserted-by":"publisher","unstructured":"Zhang X, Ma H, Gao Y, et al. Tumor Microenvironment: Signal Transduct Biomolecules. 2024;14(4). https:\/\/doi.org\/10.3390\/biom14040438.","DOI":"10.3390\/biom14040438"},{"issue":"4","key":"7355_CR78","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L, et al. Tumor Microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 2019;178(4):795\u2013806. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008.","journal-title":"Cell"},{"key":"7355_CR79","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fcimb.2016.00179","volume":"6","author":"AM Thomas","year":"2016","unstructured":"Thomas AM, Jesus EC, Lopes A, et al. Tissue-Associated bacterial alterations in rectal carcinoma patients revealed by 16S rRNA community profiling. Front Cell Infect Microbiol. 2016;6:179. https:\/\/doi.org\/10.3389\/fcimb.2016.00179.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"7355_CR80","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/08820139.2017.1407787","volume":"47","author":"N Elwan","year":"2018","unstructured":"Elwan N, Salem ML, Kobtan A, et al. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest. 2018;47(2):169\u201380. https:\/\/doi.org\/10.1080\/08820139.2017.1407787.","journal-title":"Immunol Invest"},{"issue":"11","key":"7355_CR81","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2174\/1568009619666190718141647","volume":"19","author":"F El-Gebaly","year":"2019","unstructured":"El-Gebaly F, Abou-Saif S, Elkadeem M, et al. Study of serum soluble programmed death ligand 1 as a prognostic factor in hepatocellular carcinoma in Egyptian patients. Curr Cancer Drug Targets. 2019;19(11):896\u2013905. https:\/\/doi.org\/10.2174\/1568009619666190718141647.","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"7355_CR82","doi-asserted-by":"publisher","first-page":"2432222","DOI":"10.1080\/20565623.2024.2432222","volume":"11","author":"D Ghalwash","year":"2025","unstructured":"Ghalwash D, Ammar A, Abou-Bakr A, Diab AH, El-Gawish A. Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population. Future Sci OA. 2025;11(1):2432222. https:\/\/doi.org\/10.1080\/20565623.2024.2432222.","journal-title":"Future Sci OA"},{"issue":"1","key":"7355_CR83","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1186\/s12903-025-06391-7","volume":"25","author":"A Abou-Bakr","year":"2025","unstructured":"Abou-Bakr A, Ahmed E, William H, Hassanein FEA. Frequency of periodontal disease in head and neck cancer patients after radiation therapy: a cross-sectional study. BMC Oral Health. 2025;25(1):1008. https:\/\/doi.org\/10.1186\/s12903-025-06391-7.","journal-title":"BMC Oral Health"},{"issue":"7","key":"7355_CR84","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00432-025-06213-x","volume":"151","author":"FEA Hassanein","year":"2025","unstructured":"Hassanein FEA, Mikhail C, Elkot S, Abou-Bakr A. L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial. J Cancer Res Clin Oncol. 2025;151(7):198. https:\/\/doi.org\/10.1007\/s00432-025-06213-x.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7355_CR85","doi-asserted-by":"publisher","first-page":"106375","DOI":"10.1016\/j.intimp.2020.106375","volume":"82","author":"MT Abdel Ghafar","year":"2020","unstructured":"Abdel Ghafar MT, Morad MA, El-Zamarany EA, et al. Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: A pilot study. Int Immunopharmacol. 2020;82:106375. https:\/\/doi.org\/10.1016\/j.intimp.2020.106375.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"7355_CR86","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/meg.0000000000000688","volume":"28","author":"E Sheta","year":"2016","unstructured":"Sheta E, El-Kalla F, El-Gharib M, et al. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study. Eur J Gastroenterol Hepatol. 2016;28(10):1198\u2013203. https:\/\/doi.org\/10.1097\/meg.0000000000000688.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07355-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:03:36Z","timestamp":1764072216000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7355"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07355-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"13 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in line with ethical standards and received approval from the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences (Approval No. NCC2025C-626).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all individuals whose data are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1347"}}